Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $106.8400 (2.51%) ($103.1700 - $107.4400) on Thu. Dec. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 46 | Latest Price | $106.8400(2.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.3% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
Resistance Level | $108.05 | 5 Day Moving Average | $106.24(0.56%) | 10 Day Moving Average | $107.77(-0.86%) | 20 Day Moving Average | $108.05(-1.12%) | To recent high | -5.9% | To recent low | 10.2% | Market Cap | $1.717b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |